Versatile and on-demand biologics co-production in yeast
Jicong Cao,
Pablo Perez-Pinera,
Ky Lowenhaupt,
Ming-Ru Wu,
Oliver Purcell,
Cesar de la Fuente-Nunez and
Timothy K. Lu ()
Additional contact information
Jicong Cao: Massachusetts Institute of Technology
Pablo Perez-Pinera: Massachusetts Institute of Technology
Ky Lowenhaupt: Massachusetts Institute of Technology
Ming-Ru Wu: Massachusetts Institute of Technology
Oliver Purcell: Massachusetts Institute of Technology
Cesar de la Fuente-Nunez: Massachusetts Institute of Technology
Timothy K. Lu: Massachusetts Institute of Technology
Nature Communications, 2018, vol. 9, issue 1, 1-13
Abstract:
Abstract Current limitations to on-demand drug manufacturing can be addressed by technologies that streamline manufacturing processes. Combining the production of two or more drugs into a single batch could not only be useful for research, clinical studies, and urgent therapies but also effective when combination therapies are needed or where resources are scarce. Here we propose strategies to concurrently produce multiple biologics from yeast in single batches by multiplexing strain development, cell culture, separation, and purification. We demonstrate proof-of-concept for three biologics co-production strategies: (i) inducible expression of multiple biologics and control over the ratio between biologic drugs produced together; (ii) consolidated bioprocessing; and (iii) co-expression and co-purification of a mixture of two monoclonal antibodies. We then use these basic strategies to produce drug mixtures as well as to separate drugs. These strategies offer a diverse array of options for on-demand, flexible, low-cost, and decentralized biomanufacturing applications without the need for specialized equipment.
Date: 2018
References: Add references at CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
https://www.nature.com/articles/s41467-017-02587-w Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-017-02587-w
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-017-02587-w
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().